FDI worth Rs.1,034 cr cleared

February 10, 2012 11:31 pm | Updated 11:31 pm IST - NEW DELHI:

The Central Government on Friday approved 20 foreign direct investment proposals (FDI), including that of Fluke South East Asia Pte, APF II India Investments Mauritius and Edict Pharmaceuticals, that envisage a total investment of Rs.1,034.37 crore.

The proposals were cleared following recommendations of the Foreign Investment Promotion Board (FIPB).

The government cleared Singapore-based Fluke South East Asia Pte's Rs.400 crore proposal to incorporate an investing company to make downstream investments in other Indian firms engaged in wholesale trading and related activities.

Besides, the Board cleared a proposal of Mauritius-based APF II India Investments Pvt Ltd's investment of Rs.300 crore.

Edict Pharmaceuticals' proposal to induct Rs.171.53 crore by way of transfer of 100 per cent equity to a foreign investor has also been cleared, an official release said.

However, decision on 15 proposals, including that of Ashok Leyland Defence Systems, was deferred and two others were rejected, it said.

Meanwhile, one proposal relating to Ordain Health Care Global was withdrawn.

The proposal of Mauritius-based Multiples Private Equity Fund I Ltd seeking induction of foreign equity worth Rs.50.94 crore for acquisition of equity shares of a company engaged in the operation of automated and online power exchange was also cleared.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.